Artificial Intelligence and Evidence-Informed Policy: Emerging Challenges and Opportunities

Key Takeaways

• AI speeds evidence synthesis across health policy cycle
• Bias and opacity remain major governance challenges
• Human oversight and multidisciplinary teams essential for responsible AI use
• Living evidence approaches enable iterative, data‑driven decisions

Pulse Analysis

The WHO’s new discussion paper arrives at a pivotal moment when health systems worldwide are grappling with ever‑growing data volumes. AI’s capacity to ingest disparate datasets—from electronic health records to real‑time surveillance—offers policymakers a faster route to evidence synthesis, enabling more timely identification of health threats and formulation of responsive policies. By embedding predictive analytics and scenario modeling into the policy cycle, AI can transform static reports into dynamic tools that anticipate outcomes and guide resource allocation with unprecedented precision.

Yet the promise of AI is tempered by significant challenges. Algorithmic bias can perpetuate existing health inequities, while opaque decision‑making processes erode stakeholder confidence. Data governance frameworks often lag behind technological advances, leaving gaps in privacy protection and cross‑border data sharing. Moreover, regulatory structures lack the agility to keep pace with rapid AI innovation, creating uncertainty for both developers and health authorities. Addressing these risks requires a coordinated governance approach that aligns AI ethics with the principles of evidence‑informed policy.

To translate AI’s potential into tangible health improvements, the WHO paper recommends a suite of practical measures. Human oversight must remain central, ensuring that AI outputs are interpreted within the broader context of clinical expertise and societal values. Multidisciplinary collaboration—bringing together data scientists, clinicians, ethicists and policymakers—can mitigate bias and enhance relevance. Adopting "living evidence" models allows policies to evolve as new data emerge, while risk‑based regulation provides a flexible yet accountable framework. Together, these strategies aim to embed AI responsibly within health policy, fostering better outcomes and sustained public trust.